TLNRD1 is a CCM complex component and regulates endothelial barrier integrity

Neil J. Ball, Sujan Ghimire, Gautier Follain, Ada O. Pajari, Diana Wurzinger, Monika Vaitkevičiūtė, Alana R. Cowell, Bence Berki, Johanna Ivaska, Ilkka Paatero, Benjamin T. Goult, Guillaume Jacquemet

Journal of Cell Biology (2024)

Published on December 8, 2025

DOI: https://doi.org/10.1083/jcb.202310030

Abstract

We previously identified talin rod domain-containing protein 1 (TLNRD1) as a potent actin-bundling protein in vitro. Here, we report that TLNRD1 is expressed in the vasculature in vivo. Its depletion leads to vascular abnormalities in vivo and modulation of endothelial cell monolayer integrity in vitro. We demonstrate that TLNRD1 is a component of the cerebral cavernous malformations (CCM) complex through its direct interaction with CCM2, which is mediated by a hydrophobic C-terminal helix in CCM2 that attaches to a hydrophobic groove on the four-helix domain of TLNRD1. Disruption of this binding interface leads to CCM2 and TLNRD1 accumulation in the nucleus and actin fibers. Our findings indicate that CCM2 controls TLNRD1 localization to the cytoplasm and inhibits its actin-bundling activity and that the CCM2-TLNRD1 interaction impacts endothelial actin stress fiber and focal adhesion formation. Based on these results, we propose a new pathway by which the CCM complex modulates the actin cytoskeleton and vascular integrity.
← Back to Publications
O. Parilova et al. • 2026 • Nucleic Acids Research
Abstract RNA polymerase I (Pol I) synthesizes precursor ribosomal RNA, a key step in ribosome biogenesis. Elevated Pol I activity...
M. Gluud et al. • 2026 • Allergy
ABSTRACT Background Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T‐cell lymphoma...
G. Follain et al. • 2026 • The EMBO Journal
Abstract The rapid, transient, and unpredictable nature of interactions between circulating cells and the endothelium challenges the investigation of these...